Atom Investors LP increased its stake in Enfusion, Inc. (NYSE:ENFN – Free Report) by 2.4% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 252,978 shares of the company’s stock after purchasing an additional 5,858 shares during the quarter. Atom Investors LP owned approximately 0.20% of Enfusion worth $2,401,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also modified their holdings of the company. RiverPark Advisors LLC acquired a new position in Enfusion during the 2nd quarter valued at $68,000. Arizona State Retirement System acquired a new position in shares of Enfusion during the second quarter valued at about $86,000. Price T Rowe Associates Inc. MD bought a new stake in shares of Enfusion in the first quarter valued at about $102,000. Harbor Capital Advisors Inc. increased its stake in Enfusion by 12.4% during the third quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company’s stock valued at $113,000 after acquiring an additional 1,315 shares during the period. Finally, Belvedere Trading LLC acquired a new position in Enfusion in the 3rd quarter valued at approximately $114,000. 81.05% of the stock is currently owned by institutional investors and hedge funds.
Enfusion Trading Up 2.0 %
Shares of ENFN stock opened at $10.14 on Tuesday. The company has a market capitalization of $1.30 billion, a P/E ratio of 253.50, a P/E/G ratio of 3.72 and a beta of 0.93. Enfusion, Inc. has a 12 month low of $7.52 and a 12 month high of $10.40. The stock has a 50 day moving average of $9.33 and a two-hundred day moving average of $8.89.
Enfusion Profile
Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.
Featured Articles
- Five stocks we like better than Enfusion
- How to Most Effectively Use the MarketBeat Earnings Screener
- How to Master Trading Discipline: Overcome Emotional Challenges
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- Bank Stocks – Best Bank Stocks to Invest In
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Want to see what other hedge funds are holding ENFN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enfusion, Inc. (NYSE:ENFN – Free Report).
Receive News & Ratings for Enfusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enfusion and related companies with MarketBeat.com's FREE daily email newsletter.